Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them. As it stands, patients from lower-income and rural communities often face substantial economic barriers to participation, including lost wages…
Read More
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
